The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. Radioimmunotherapy marks a ...
The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of MVID and/or ...
An NIH grant will allow Chelsie E. Armbruster, PhD, to study pathogens than cause urinary tract infections, the most common infections worldwide and a leading cause of morbidity and health care ...